<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">06535</article-id><article-id pub-id-type="doi">10.7554/eLife.06535</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group></article-categories><title-group><article-title>Compensatory induction of MYC expression by sustained CDK9 inhibition via a BRD4-dependent mechanism</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-10844"><name><surname>Lu</surname><given-names>Huasong</given-names></name><aff><institution content-type="dept">Department of Molecular and Cell Biology</institution>, <institution>University of California, Berkeley</institution>, <addr-line><named-content content-type="city">Berkeley</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28089"><name><surname>Xue</surname><given-names>Yuahua</given-names></name><aff><institution content-type="dept">Innovation Center of Cell Signaling Network, School of Pharmaceutical Sciences</institution>, <institution>Xiamen University</institution>, <addr-line><named-content content-type="city">Xiamen</named-content></addr-line>, <country>China</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28102"><name><surname>Yu</surname><given-names>Guoying K</given-names></name><aff><institution>Novartis Institute for BioMedical Research</institution>, <addr-line><named-content content-type="city">Emeryville</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28100"><name><surname>Arias</surname><given-names>Carolina</given-names></name><aff><institution>Novartis Institute for BioMedical Research</institution>, <addr-line><named-content content-type="city">Emeryville</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28103"><name><surname>Lin</surname><given-names>Julie</given-names></name><aff><institution>Novartis Institute for BioMedical Research</institution>, <addr-line><named-content content-type="city">Emeryville</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28104"><name><surname>Fong</surname><given-names>Susan</given-names></name><aff><institution>Novartis Institute for BioMedical Research</institution>, <addr-line><named-content content-type="city">Emeryville</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28105"><name><surname>Faure</surname><given-names>Michel</given-names></name><aff><institution>Novartis Institute for BioMedical Research</institution>, <addr-line><named-content content-type="city">Emeryville</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28106"><name><surname>Weisburd</surname><given-names>Ben</given-names></name><aff><institution>Novartis Institute for BioMedical Research</institution>, <addr-line><named-content content-type="city">Emeryville</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12539"><name><surname>Ji</surname><given-names>Xiaodan</given-names></name><aff><institution content-type="dept">Department of Molecular and Cell Biology</institution>, <institution>University of California, Berkeley</institution>, <addr-line><named-content content-type="city">Berkeley</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28107"><name><surname>Mercier</surname><given-names>Alexandre</given-names></name><aff><institution>Novartis Institute for BioMedical Research</institution>, <addr-line><named-content content-type="city">Emeryville</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28108"><name><surname>Sutton</surname><given-names>James</given-names></name><aff><institution>Novartis Institute for BioMedical Research</institution>, <addr-line><named-content content-type="city">Emeryville</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-12714"><name><surname>Luo</surname><given-names>Kunxin</given-names></name><aff><institution content-type="dept">Department of Molecular and Cell Biology</institution>, <institution>University of California, Berkeley</institution>, <addr-line><named-content content-type="city">Berkeley</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28098"><name><surname>Gao</surname><given-names>Zhenhai</given-names></name><aff><institution>Novartis Institute for BioMedical Research</institution>, <addr-line><named-content content-type="city">Emeryville</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-2968"><name><surname>Zhou</surname><given-names>Qiang</given-names></name><aff><institution content-type="dept">Department of Molecular and Cell Biology</institution>, <institution>University of California, Berkeley</institution>, <addr-line><named-content content-type="city">Berkeley</named-content></addr-line>, <country>United States</country><email>qzhou@berkeley.edu</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1189"><name><surname>Struhl</surname><given-names>Kevin</given-names></name><role>Reviewing editor</role><aff><institution>Harvard Medical School</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>17</day><month>06</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e06535</elocation-id><supplementary-material><ext-link xlink:href="elife-06535-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>18</day><month>01</month><year>2015</year></date><date date-type="accepted"><day>16</day><month>06</month><year>2015</year></date></history><permissions><copyright-statement>Â© 2015, Lu et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Lu et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>CDK9 is the kinase subunit of P-TEFb that enables RNA polymerase (Pol) II's transition from promoter-proximal pausing to productive elongation. Although considerable interest exists in CDK9 as a therapeutic target, little progress has been made due to lack of highly selective inhibitors. Here, we describe the development of i-CDK9 as such an inhibitor that potently suppresses CDK9 phosphorylation of substrates and causes genome-wide Pol II pausing. While most genes experience reduced expression, MYC and other primary response genes increase expression upon sustained i-CDK9 treatment. Essential for this increase, the bromodomain protein BRD4 captures P-TEFb from 7SK snRNP to deliver to target genes and also enhances CDK9's activity and resistance to inhibition. Because the i-CDK9-induced MYC expression and binding to P-TEFb compensate for P-TEFb's loss of activity, only simultaneously inhibiting CDK9 and MYC/BRD4 can efficiently induce growth arrest and apoptosis of cancer cells, suggesting the potential of a combinatorial treatment strategy.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></back></article>